Patients present with HTN at very young ages along with atypical sexual development. Glucocorticoid supplementation to suppress ACTH expression treats HTN; potentially add MR antagonists for better control. Therapy should also be individualized to address aspects of sexual dysfunction. Here, NR3C2 is linked to hypertensive disorder.